Multiple Antigen-Engineered DC Vaccine for Melanoma
Clinical trial NCT01622933 · COMPLETED
Trial details
- NCT number
- NCT01622933
- Sponsor
- Lisa H. Butterfield, Ph.D.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2016-05-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.